Ideally, specific treatment for a cancer patient is decided by a multidisciplinary tumor board, integrating prior clinical experience, published data, and patient-specific factors to develop a ...
To address the limitations of binary pCR classification, Pusztai and colleagues developed the residual cancer burden (RCB) ...